Lab & Diagnostic Provider Industry News Best Practices in Revenue Cycle Management For Laboratories Top Trends of 2024 and Takeaways of the Takedown For Laboratories Unlocking Success: Early-Stage Lab Commercialization Checklist For Laboratories Maximizing Revenue Cycle Efficiency with Expected Reimbursement Strategies For Laboratories Lucid Diagnostics Case Study & Interview For Laboratories FDA’s New LDT Rule Unveiled: Key Insights and Lab Preparations For Laboratories Key Regulatory Shifts Ahead: Embracing Change in the Lab Industry For Hospitals & Physician Groups From Paper to Progress: Automate Remittance Advice Processing For Laboratories FDA’s Proposed Rule on LDTs and Implications for Laboratories For Laboratories CMS Pushes Back Final Pricing on Genomic Sequencing Procedure Codes For Laboratories FDA Proposes Rule to Enhance Safety and Effectiveness of LDTs For Laboratories UnitedHealthcare Cutting Back on Prior Authorizations For Laboratories Are You Using Analytics to Maximize Your Laboratory’s Reimbursement? For Laboratories Protecting our Future—Celebrating Lab Week For Hospitals & Physician Groups Year in Review: Your Resource Library for Optimizing the Revenue Cycle For Laboratories Improve Your Cash Flow with Patient Payment Portal For Laboratories Give Patients What They Want for a Healthier Revenue Cycle For Laboratories The Lab Revenue Cycle is Increasingly Patient-Facing and Digital For Laboratories Giving the Gift of Health – Lab Professionals Week For Hospitals & Physician Groups Keep Your Cash Flow Steady Despite Claims Volume Fluctuation For Hospitals & Physician Groups Is Lack of RCM Automation Putting Your Revenue At Risk? For Laboratories Best Practices for Labs to Remain Competitive For Laboratories Prevent Denials with Early Insight into Patient and Payer Information For Laboratories Celebrating Lab Professionals Across the Industry For Laboratories A Final Verdict in ACLA vs Azar? For Laboratories UHC Genetic and Molecular Lab Testing Updates effective June 1, 2021 For Laboratories Laboratory News Brief – March 2021 For Laboratories How To Address Top Revenue Cycle Challenges Facing Labs For Laboratories UnitedHealthcare Designated Diagnostic Provider Program (DDP) set for July 1 Launch For Laboratories Biodesix For Laboratories Potential New CMS COVID-19 Testing Policies & Pricing on the Horizon? For Laboratories Examine COVID Claims to Find RCM Weaknesses in Your Lab For Hospitals & Physician Groups New CMS Rule Attempts to Alleviate the Prior Authorization Burden For Hospitals & Physician Groups New COVID-19 Testing Price Transparency Requirements Effective Immediately For Hospitals & Physician Groups Government Takes Action to Ensure Coverage of COVID-19 Vaccine For Laboratories COVID-19 Testing Payments and Regulations: What Labs Need to Know For Laboratories How to Bill for Medicare Add-On Payment for COVID-19 Diagnostic Tests For Laboratories Larger Payments for Labs Producing Faster COVID-19 Results For Laboratories COVID-19 Test Pricing: Know the Facts, Protect Your Lab’s Reputation For Hospitals & Physician Groups Women Among the Hardest Hit Financially by COVID-19 Pandemic For Laboratories UHC Deadline for Lab Test Registry Delayed Indefinitely For Laboratories Navigating Reimbursement for Liquid Biopsy Cancer Testing For Laboratories COVID-19: Insurers Exempt from Covering Workplace Testing For Laboratories A New Era of Consumerism Facing Labs Today – How Do You Stay Competitive? For Laboratories Is Your Lab Collecting What It’s Owed? For Laboratories Surprise Billing Legislation: Ways to Mitigate Your Risk Compliance, Privacy & Security MIPS Scoring for Facility-based Pathologists: 3 Things You Need to Know For Laboratories Seven Keys to Improve Out-of-Network Collections For Laboratories Is Your Lab Applicable Under the New PAMA Definition? For Laboratories Patient Bad Debt Impacting Your Bottom Line? For Laboratories Patient Access Antidote: Retaining More Revenue with Front End Solutions For Laboratories Patient Access Antidote: How Labs Can Retain More Revenue For Laboratories Pursue LDT Revenue Cycle Success with Cross-functional Collaboration For Laboratories Quadax Presents Strategic Considerations for Managing the Increasing Patient Cost-Share Trend Compliance, Privacy & Security FASB ASC 606: Prepare Your Laboratory for a Successful Transition For Laboratories Cross-functional Collaboration is Key to Diagnostic Test Commercialization For Laboratories ASC 606: Lessons Learned and What You Need to Know For Laboratories Mitigate Prior Authorization Challenges: A Guide to Best Practices For Laboratories 14 Day Rule Regarding ADLT and MolPath Tests Continues to Show Movement For Laboratories Prior Authorization – The Lab’s Dilemma For Laboratories Accelerate Receivables: Monitor KPIs for A/R Search and Rescue For Laboratories Improve Reimbursement Outcomes with Patient Access Management For Laboratories Gaining Coverage for Your Lab’s New Diagnostic Test For Laboratories OPPS 2018 Revisions: Outpatient 14-Day Rule Changes to Laboratory DOS Policy For Laboratories Living with PAMA–What is Your Lab’s Prognosis? For Laboratories Defining Your Hospital Lab Program’s Value in the Face of PAMA Cuts For Laboratories Is Your Lab Aware of CMS Claim Requirements for “Unlisted” Test Codes? For Laboratories Strategies for Managing Genetic and Molecular Test Preauthorization For Hospitals & Physician Groups Start Smart! Split Remits to Match and Relieve A/R For Hospitals & Physician Groups Fielding an All Star Healthcare Revenue Cycle Operations Team Compliance, Privacy & Security RAC Audits and What They Mean for Healthcare Providers Compliance, Privacy & Security FASB New Standard on Revenue Recognition – Are You Ready for ASC 606? For Laboratories Leading Industry Innovation in the Healthcare Heartland For Laboratories Implications of Narrow Healthcare Networks on Laboratory Providers For Hospitals & Physician Groups How to Improve Payments as HDHPs Increase Patient Responsibility For Laboratories 4 Strategies for Molecular Diagnostic Labs to Maximize Reimbursement
